Schizophrenia and Related Disorders — Employment Outcomes After Vocational Training
Citation(s)
Arbesman M, Logsdon DW Occupational therapy interventions for employment and education for adults with serious mental illness: a systematic review. Am J Occup Ther. 2011 May-Jun;65(3):238-46. Review.
Bond GR, Drake RE, Becker DR An update on randomized controlled trials of evidence-based supported employment. Psychiatr Rehabil J. 2008 Spring;31(4):280-90. doi: 10.2975/31.4.2008.280.290. Review.
Chuang WF, Hwang E, Lee HL, Wu SL An in-house prevocational training program for newly discharged psychiatric inpatients: exploring its employment outcomes and the predictive factors. Occup Ther Int. 2015 Jun;22(2):94-103. doi: 10.1002/oti.1388. Epub 2015 Mar 16.
Jang Y, Wang YT, Lin MH Factors affecting employment outcomes for people with disabilities who received Disability Employment Services in Taiwan. J Occup Rehabil. 2014 Mar;24(1):11-21. doi: 10.1007/s10926-013-9433-1.
Waghorn G, Dias S, Gladman B, Harris M, Saha S A multi-site randomised controlled trial of evidence-based supported employment for adults with severe and persistent mental illness. Aust Occup Ther J. 2014 Dec;61(6):424-36. doi: 10.1111/1440-1630.12148. Epub 2014 Oct 4.
Employment Outcomes After In-House Vocational Training Programs for Individuals With Chronic Psychiatric Disorders
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
